Provided by Tiger Fintech (Singapore) Pte. Ltd.

AbbVie

198.47
+5.132.65%
Post-market: 199.030.5605+0.28%19:59 EDT
Volume:6.43M
Turnover:1.27B
Market Cap:351.09B
PE:84.82
High:198.98
Open:195.17
Low:194.63
Close:193.34
Loading ...

Top Cancer Stocks to Buy to Boost Your Portfolio's Health

Zacks
·
16 Apr

Top Research Reports for AbbVie, TJX & Charles Schwab

Zacks
·
16 Apr

AbbVie Inc. (ABBV): One of the High Growth Forever Dividend Stocks to Invest In

Insider Monkey
·
15 Apr

AbbVie Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
15 Apr

ABBV vs. MRK: Which Drug Giant is a Better Buy Now?

Zacks
·
14 Apr

Is AbbVie Inc. (ABBV) the Best Stock for 15 Years?

Insider Monkey
·
14 Apr

Block, Simon, Sirius, AbbVie, Apple: Trending by Analysts

TIPRANKS
·
12 Apr

AbbVie Aesthetics Line Faces Potential Risk in Current Macro Environment, UBS Says

MT Newswires Live
·
12 Apr

Class Action Filed Against Cerevel Therapeutics Holdings, Inc. (ABBV) Seeking Recovery for Investors – Contact Levi & Korsinsky LLP

TIPRANKS
·
11 Apr

Pharma Stock Roundup: EU Nod to Expanded Use of ABBV, AZN Drugs & More

Zacks
·
11 Apr

Citigroup Adjusts Price Target on AbbVie to $210 From $215, Keeps Buy Rating

MT Newswires Live
·
11 Apr

Pfizer Stock Falls to New 52-Week Low: Should You Buy the Dip?

Zacks
·
10 Apr

Pharma Shares Reverse Losses After Tariff Pause

Dow Jones
·
10 Apr

Why drug stocks are no longer a safe haven from the stock market's turmoil

Dow Jones
·
09 Apr

Pharma Stocks Slide Further After Trump Reiterates Tariff Threats on Drugs -- Update

Dow Jones
·
09 Apr

Morgan Stanley Adjusts Price Target on AbbVie to $241 From $239, Keeps Overweight Rating

MT Newswires Live
·
09 Apr

Shares of Drugmakers Down After Trump Threatens Tariffs on Sector

THOMSON REUTERS
·
09 Apr

AbbVie price target raised to $241 from $239 at Morgan Stanley

TIPRANKS
·
09 Apr

US STOCKS-Futures tumble as China hits back with more barriers on US goods

Reuters
·
09 Apr

BUZZ-US drugmakers fall as Trump threatens tariffs again

Reuters
·
09 Apr